- Home
- YOU vs TLX Comparison
YOU vs TLX Comparison
Compare YOU & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YOU
- TLX
- Stock Information
- Founded
- YOU 2010
- TLX 2015
- Country
- YOU United States
- TLX Australia
- Employees
- YOU N/A
- TLX N/A
- Industry
- YOU Computer Software: Prepackaged Software
- TLX Biotechnology: Pharmaceutical Preparations
- Sector
- YOU Technology
- TLX Health Care
- Exchange
- YOU Nasdaq
- TLX Nasdaq
- Market Cap
- YOU 3.5B
- TLX 3.2B
- IPO Year
- YOU 2021
- TLX N/A
- Fundamental
- Price
- YOU $31.55
- TLX $10.92
- Analyst Decision
- YOU Buy
- TLX Strong Buy
- Analyst Count
- YOU 6
- TLX 4
- Target Price
- YOU $36.17
- TLX $21.00
- AVG Volume (30 Days)
- YOU 1.9M
- TLX 181.3K
- Earning Date
- YOU 11-06-2025
- TLX 01-01-0001
- Dividend Yield
- YOU 2.47%
- TLX N/A
- EPS Growth
- YOU 105.20
- TLX N/A
- EPS
- YOU 1.59
- TLX 0.04
- Revenue
- YOU $835,529,000.00
- TLX $664,225,558.00
- Revenue This Year
- YOU $16.31
- TLX N/A
- Revenue Next Year
- YOU $11.04
- TLX N/A
- P/E Ratio
- YOU $19.54
- TLX $235.46
- Revenue Growth
- YOU 19.85
- TLX 55.35
- 52 Week Low
- YOU $21.67
- TLX $8.93
- 52 Week High
- YOU $39.00
- TLX $30.36
- Technical
- Relative Strength Index (RSI)
- YOU 40.68
- TLX 58.70
- Support Level
- YOU $29.97
- TLX $9.47
- Resistance Level
- YOU $31.20
- TLX $10.28
- Average True Range (ATR)
- YOU 1.25
- TLX 0.24
- MACD
- YOU -0.28
- TLX 0.11
- Stochastic Oscillator
- YOU 27.91
- TLX 79.67
About YOU Clear Secure Inc.
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in the creation of a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports which helps to make the travel experience safe and easy.
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.